-
Study aim
-
The present study seeks to investigate transcranial direct-current stimulation (tDCS) and compare it with High definition- tDCS (HD-tDCS) to evaluate their effect on symptoms of restless legs syndrome.
-
Design
-
This is a clinical trial research include pre-test, post-test, one-month follow-up and control group. There are parallel groups of 45 subjects which randomly divide into three groups (two experimental and one control group).
-
Settings and conduct
-
This is a randomized clinical trial study in which the double blind method will be used. Therefore we refer to consulting Centers of Yazd and by using the convenience sampling method, people with discomfort and complaints of restless legs syndrome are suggested to participate in the study. We offer neurotherapy to satisfy the clients to participate in the research.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Diagnosis of the disorder by a psychiatrist, Rejecting differential diagnosis by a neurologist, Aged between 18 to 75 years, Not suffering from cardiovascular disease and diabetes, Not Smoking, Non-pregnancy.
Exclusion criteria: Dissatisfaction to participate in the research, Having a type of motor or cognitive disabilities, Receiving simultaneous psychiatric treatment, History of seizure disorders, Having a pacemaker
-
Intervention groups
-
The first intervention group received transcranial direct-current stimulation (tDCS) at 4 mA (positive stimulation) over 10 consecutive sessions.
The second intervention group received High definition-tDCS (HD-tDCS) at 2 mA (positive stimulation) over 10 consecutive sessions.
Ten sessions of HD-tDCS without electricity flow (sham mode) will be used for the control group.
-
Main outcome variables
-
Cognitive Symptoms, Depression, Severity of restless legs syndrome.